In: personalized medicine

Slone Partners, Where People Are Our Science®, Announces Insights: Scientific Healthcare Investing 2018 Panel Event With Leaders In The Investment Community

Produced in conjunction with Biocom, the October 25, 2018 discussion in South San Francisco explores the capital markets and conditions driving innovative companies...

PMC Series: Interview with Daniel O’Day, CEO of Roche Pharmaceuticals

Slone Partners’ 2018 PMC Interview Series debuts with an exclusive, in-depth interview of Daniel O’Day, the CEO of Roche Pharmaceuticals. A...

Biocom Slone Partners Culture

Snapshots & Sound Bites from Biocom + Slone Partners’ INSIGHTS: Culture as a Cornerstone, Bay Area Perspectives

The latest in our series of dynamic live programming Slone Partners produces in major U.S. healthcare hubs addressed the essentials of...

Leadership Series: Insights, Culture As A Cornerstone

How To Activate Board Members and Senior Executives To Build Thriving Cultural Environments For Scientific Healthcare Companies & Beyond As part...

cultural leaders

Cultural Leaders Speak

As a preview to Slone Partners upcoming event INSIGHTS: CULTURE AS A CORNERSTONE in Boston June 6, 2018, we asked our...

Top 5 reasons

The Top 5 Reasons Why Retained Search Is Personalized Medicine’s Best Ally

With quickly-changing marketplaces, retained search firms are more often collaborating with high-growth companies to discover fresh, consumer-centric talent. Historically, precision medicine...

Dr. Michael Sherman

PMC Series: Interview with Michael Sherman, M.D., CMO & SVP of Health Services at Harvard Pilgrim Health Care

Leading up to the Annual Personalized Medicine Conference hosted in Boston this November, Slone Partners presents its exclusive interview series featuring...